Symptomatic treatmentversus combination chemotherapy for patients with extensive non-small cell lung cancer (Q67915187)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1849786%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Symptomatic treatment versus combination chemotherapy for patients with extensive non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1849786%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Symptomatic treatmentversus combination chemotherapy for patients with extensive non-small cell lung cancer (English)

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

9 December 2022

1 reference

non-small-cell lung carcinoma

1 reference

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

9 December 2022

1

S Kaasa

1 reference

19 September 2019

2

E. Lund

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849786

9 December 2022

author name string

E. Thorud

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849786

9 December 2022

R. Hatlevoll

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849786

9 December 2022

H. Høst

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849786

9 December 2022

language of work or name

English

0 references

publication date

1 May 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1849786%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

15 May 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1849786

full work available at URL

9 December 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

9 December 2022

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

9 December 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1849786%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1849786%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1849786%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

2443-2447

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1849786%20AND%20SRC:MED&resulttype=core&format=json

A randomized study evaluating radiotherapy versus chemotherapy in patients with inoperable non-small cell lung cancer

19 September 2019

cites work

1

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

9 December 2022

Cancer Treatment Reports

2

65

979

Aisner

1981

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

cis-Platinum (DDP) and VP 16-213 (etoposide) combination chemotherapy for advanced non-small cell lung cancer. A phase II clinical trial

9 December 2022

4

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules

9 December 2022

6

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium)

9 December 2022

7

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

9 December 2022

Cancer Treatment Reports

8

63

2107

Casper

1969

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

9 December 2022

Cancer Treatment Reports

9

62

843

Eagan

1978

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

Proceedings of the American Association for Cancer Research

9 December 2022

10

20

230

Mabel

1979

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium)

9 December 2022

11

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma.

9 December 2022

12

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

9 December 2022

15

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

European Journal of Cancer & Clinical Oncology

9 December 2022

16

24

1834

Callerino

1988

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

9 December 2022

18

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

Quality of life of lung cancer patients in a randomized clinical trial evaluated by a psychosocial well-being questionnaire

9 December 2022

19

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

Toxicity, physical function and everyday activity reported by patients with inoperable non-small cell lung cancer in a randomized trial (chemotherapy versus radiotherapy)

9 December 2022

20

1 reference

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(19910515)67:10%3C2443::AID-CNCR2820671008%3E3.0.CO;2-K

9 December 2022

Identifiers

10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1849786%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference